Anavex Life Sciences
AVXL
#7271
Rank
NZ$0.75 B
Marketcap
NZ$8.18
Share price
2.37%
Change (1 day)
-47.26%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.93

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.93. a decrease over its 2024 EPS that were of NZ-$0.89.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.933.85%
2024NZ-$0.89-13.33%
2023NZ-$1.03-3.23%
2022NZ-$1.0714.81%
2021NZ-$0.9320%
2020NZ-$0.77-16.67%
2019NZ-$0.9338.46%
2018NZ-$0.6718.18%
2017NZ-$0.57-21.43%
2016NZ-$0.72-35.38%
2015NZ-$1.12-36.27%
2014NZ-$1.75112.5%
2013NZ-$0.83-58.62%
2012NZ-$1.99-0%
2011NZ-$1.99-29.27%
2010NZ-$2.8251.85%
2009NZ-$1.86-0%
2008NZ-$1.86237.5%
2007NZ-$0.55
2006N/A-100%
2005NZ-$0.06876499.97%
2004NZ-$0.01146

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$4.11-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.72-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$51.40 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08594-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA